Avet Pharmaceuticals Inc.
Dan Lukasiewicz has a diverse work experience in the pharmaceutical industry. Dan started their career at Aurobindo Pharma U.S.A., where they held various marketing roles, including Marketing Manager, Marketing Associate, and Rebate Analyst. During their time at Aurobindo Pharma U.S.A., they implemented new systems and processes to improve sales performance and customer experience. Dan then joined Zydus Pharmaceuticals USA, Inc. as a Corporate Account Manager before moving to Avet Pharmaceuticals Inc., where they held positions such as Sr. Manager of Marketing Operations, Director of Commercial Operations, and Senior Director of Commercial Marketing. Dan is currently serving as the Vice President of Sales and Marketing at Avet Pharmaceuticals Inc. Dan has also had internship experiences in marketing and human resources roles with the Baltimore Orioles and Aurobindo Pharma U.S.A. respectively.
Dan Lukasiewicz attended Christian Brothers Academy from 2000 to 2004. There is no information provided about the degree name or field of study for this period. Subsequently, from 2004 to 2008, Dan attended Loyola University Maryland, where they obtained a Bachelor of Business Administration (B.B.A.) degree with a focus on Marketing.
This person is not in any offices
Avet Pharmaceuticals Inc.
Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Avet Pharmaceuticals provides high quality generic medicines that help patients and practitioners achieve affordable healthcare solutions. Our global supply chain network is built around centers of manufacturing and scientific excellence to provide you with the highest level of quality, safety, value and service in generics. Our drug portfolio consists of numerous products across a wide range of therapeutic categories, including: cardiovascular, oncology, metabolic disease, anti-infective, infusion and pain management. We are focused on widely utilized, established products as well as niche, high barrier-to-entry products that have limited competition and long life cycles.